EFFECTS OF EXTRACORPOREAL MEMBRANE-OXYGENATION ON MORPHINE PHARMACOKINETICS IN INFANTS

被引：45

作者：

DAGAN, O

KLEIN, J

BOHN, D

KOREN, G

机构：

[1] HOSP SICK CHILDREN,DEPT CRIT CARE,TORONTO M5G 1X8,ON,CANADA

[2] HOSP SICK CHILDREN,DEPT PEDIAT,DIV CLIN PHARMACOL TOXICOL,TORONTO M5G 1X8,ON,CANADA

[3] HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA

[4] UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA

[5] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON,CANADA

来源：

CRITICAL CARE MEDICINE | 1994年 / 22卷 / 07期

关键词：

EXTRACORPOREAL MEMBRANE OXYGENATION; MORPHINE; INFANTS; PHARMACOKINETICS; PHARMACODYNAMICS; SEDATION; DRUG METABOLISM; OPIATES; CRITICAL ILLNESS; PHARMACOLOGY; INTENSIVE CARE UNIT; PEDIATRIC;

D O I：

10.1097/00003246-199407000-00008

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Objectives: To study the effect of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics of morphine in infants. Design: A prospective, comparative study of morphine pharmacokinetics during and after ECMO. Setting: The pediatric intensive care unit at a children's hospital. Patients: Seven infants, aged 1 day to 12 months, requiring ECMO. Intervention: Infusion of morphine. Measurement and Main Results: Steady-state concentrations of morphine were used to generate a morphine clearance rate. Plasma clearance rate of morphine increased from 0.574 +/- 0.3 L/kg/hr to 1.058 +/- 0.727 L/kg/hr after discontinuation of ECMO (p <.01). Two infants experienced a clinical picture consistent with opioid withdrawal. Conclusion: Infants requiring morphine after ECMO may require higher dose rates to maintain adequate sedation.

引用

页码：1099 / 1101

页数：3

共 50 条

[1] EFFECT OF EXTRACORPOREAL MEMBRANE-OXYGENATION ON TOBRAMYCIN PHARMACOKINETICS IN SHEEP
MOLLER, JC
GILMAN, JT
KEARNS, GL
SUSSMANE, JB
RASZYNSKI, A
WOLFSDORF, J
REED, MD
CRITICAL CARE MEDICINE, 1992, 20 (10) : 1454 - 1458
[2] Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation
Geiduschek, JM
Lynn, AM
Bratton, SL
Sanders, JC
Levy, FH
Haberkern, CM
ORourke, PP
CRITICAL CARE MEDICINE, 1997, 25 (02) : 360 - 364
[3] Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates
Jeroen W. B. Peters
Brian J. Anderson
Sinno H. P. Simons
Donald R. A. Uges
Dick Tibboel
Intensive Care Medicine, 2005, 31 : 257 - 263
[4] Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates
Peters, JWB
Anderson, BJ
Simons, SHP
Uges, DRA
Tibboel, D
INTENSIVE CARE MEDICINE, 2005, 31 (02) : 257 - 263
[5] MECHANISMS OF CHANGE IN CARDIAC-PERFORMANCE IN INFANTS UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGENATION
HOLLEY, DG
SHORT, BL
KARR, SS
MARTIN, GR
CRITICAL CARE MEDICINE, 1994, 22 (11) : 1865 - 1870
[6] GENTAMICIN PHARMACOKINETICS IN NEONATES UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGENATION
COHEN, P
COLLART, L
PROBER, CG
FISCHER, AF
BLASCHKE, TF
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (08) : 562 - 566
[7] Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation
Pokorna, Pavla
Sima, Martin
Vobruba, Vaclav
Tibboel, Dick
Slanar, Ondrej
PERFUSION-UK, 2018, 33 : 80 - 86
[8] Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation
Autmizguine, Julie
Hornik, Christoph P.
Benjamin, Daniel K., Jr.
Brouwer, Kim L. R.
Hupp, Susan R.
Cohen-Wolkowiez, Michael
Watt, Kevin M.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (11) : 1204 - 1210
[9] Pharmacokinetics and Safety of Fluconazole in Young Infants Supported With Extracorporeal Membrane Oxygenation
Watt, Kevin M.
Benjamin, Daniel K., Jr.
Cheifetz, Ira M.
Moorthy, Ganesh
Wade, Kelly C.
Smith, P. Brian
Brouwer, Kim L. R.
Capparelli, Edmund V.
Cohen-Wolkowiez, Michael
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (10) : 1042 - 1047
[10] EFFECT OF EXTRACORPOREAL MEMBRANE-OXYGENATION ON NEUTROPHIL FUNCTION IN NEONATES
DEPUYDT, LE
SCHUIT, KE
SMITH, SD
CRITICAL CARE MEDICINE, 1993, 21 (09) : 1324 - 1327

← 1 2 3 4 5 →